US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kalvista Pharmaceuticals Inc

19.33

+0.38002.01%

Post-market: 19.330.00000.00%19:50 EDT

Volume:2.06M

Turnover:39.99M

Market Cap:990.13M

PE:-6.34

High:19.95

Open:19.14

Low:18.82

Close:18.95

52wk High:19.95

52wk Low:9.24

Shares:51.22M

Float Shares:27.92M

Volume Ratio:1.51

T/O Rate:7.39%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.0497

EPS(LYR):-3.0497

ROE:-190.18%

ROA:-60.98%

PB:-365.23

PE(LYR):-6.34

Loading ...

Overview Company News Filings

U.S. Earnings Preview: Before Market Open March 11

KalVista Pharmaceuticals Grants 6,750 Inducement Stock Options to New Hire

Kalvista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

DRI Healthcare posts Q4 adjusted EBITDA of USD 46.2 million +25.1%

KalVista highlights new EKTERLY sebetralstat trial data showing high patient satisfaction and earlier HAE attack treatment

KalVista Pharmaceuticals to Present at TD Cowen Annual Healthcare Conference and Citizens Life Sciences Conference

BRIEF-Kalvista Pharmaceuticals Announces Inclusion Of Ekterly® As A First-Line Therapy

International Pediatric HAE Guideline Recommends KalVista’s EKTERLY as First-Line Acute Therapy for Adolescents 12+

Kalvista Pharmaceuticals Inc - Advancing Konfident-Kid Trial, Plans Drug Application for Sebetralstat in Patients Aged 2 to 11 in Q3 2026

THOMSON REUTERS

Kalvista Pharmaceuticals Announces Inclusion of Ekterly® (Sebetralstat) as a First-Line Therapy for Adolescents 12 and Older in International Pediatric Hae Guideline

THOMSON REUTERS

KalVista Pharmaceuticals Announces New Clinical Data on EKTERLY® (sebetralstat) for Hereditary Angioedema at AAAAI 2026

KalVista Pharmaceuticals Grants Stock Options to New Employees

Kalvista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

KalVista’s Pediatric HAE Trial for Sebetralstat Reaches Completion, Setting Up a Key Catalyst for KALV

Stifel Nicolaus Sticks to Their Buy Rating for KalVista Pharmaceuticals (KALV)

Kalvista Pharmaceuticals Inc : Needham Raises Target Price to $35 From $32

THOMSON REUTERS

KalVista price target raised to $37 from $27 at H.C. Wainwright

Greenbrier, General Motors And 3 Stocks To Watch Heading Into Friday

KalVista Pharmaceuticals Gains on Strong Demand for Genetic-Disorder Treatment

Kalvista Pharmaceuticals Showcases EKTERLY as First Oral On-Demand Therapy for Hereditary Angioedema

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KALV/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KALV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KALV\",,,,,undefined,":{"symbol":"KALV","market":"US","secType":"STK","nameCN":"Kalvista Pharmaceuticals Inc","latestPrice":19.33,"timestamp":1774641600000,"preClose":18.95,"halted":0,"volume":2063633,"hourTrading":{"tag":"盘后","latestPrice":19.33,"preClose":19.33,"latestTime":"19:50 EDT","volume":27541,"amount":532336.1,"timestamp":1774655436721,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.02005277044854876,"floatShares":27916900,"shares":51222487,"eps":-3.049674,"marketStatus":"Market Closed","change":0.38,"latestTime":"03-27 16:00:00 EDT","open":19.14,"high":19.95,"low":18.815,"amount":39988081.475628,"amplitude":0.059894,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.049674,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1479790800000,"exchange":"NASDAQ","adjPreClose":18.95,"preHourTrading":{"tag":"盘前","latestPrice":19.18,"preClose":18.95,"latestTime":"09:29 EDT","volume":6106,"amount":115217.50282999998,"timestamp":1774618199999,"change":0.23,"changeRate":0.012137,"amplitude":0.054354},"postHourTrading":{"tag":"盘后","latestPrice":19.33,"preClose":19.33,"latestTime":"19:50 EDT","volume":27541,"amount":532336.1,"timestamp":1774655436721,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.507774,"optionData":{"bulkOrders":[{"symbol":"KALV","call":true,"expireDate":1778817600000,"strike":"20.0","timestamp":1774620053044,"price":2,"volume":5000,"amount":1000000,"type":"-"}]},"impliedVol":0.6937,"impliedVolPercentile":0.3745},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KALV\",,,,,undefined,":{"symbol":"KALV","floatShares":27916900,"roa":"-60.98%","roe":"-190.18%","lyrEps":-3.049674,"volumeRatio":1.507774,"shares":51222487,"dividePrice":0,"high":19.95,"amplitude":0.059894,"preClose":18.95,"low":18.815,"week52Low":9.235,"pbRate":"-365.23","psRate":"13.45","week52High":19.95,"institutionHeld":0,"latestPrice":19.33,"eps":-3.049674,"divideRate":0,"volume":2063633,"delay":0,"ttmEps":-3.049674,"open":19.14,"prevYearClose":16.15,"prevWeekClose":17,"prevMonthClose":16.28,"prevQuarterClose":16.15,"fiveDayClose":17,"twentyDayClose":16.28,"sixtyDayClose":15.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KALV\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"KALV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774425600000,"name":null,"time":"Pre-Market","dateTimestamp":1774411200000,"actualEps":null},{"market":"US","date":"2026-01-08","symbol":"KALV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1767848400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-10","symbol":"KALV","fiscalQuarterEnding":"2025/09","expectedEps":-0.96,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"post","actualEps":-0.92},{"market":"US","date":"2025-09-11","symbol":"KALV","fiscalQuarterEnding":"2025/07","expectedEps":-0.91,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1757563200000,"reportTimeType":"pre","actualEps":-1.12},{"market":"US","date":"2025-07-10","symbol":"KALV","fiscalQuarterEnding":"2025/04","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1752120000000,"reportTimeType":"pre","actualEps":-0.99}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KALV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KALV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.5556,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1738382400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KALV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KALV","date":"2026-03-27","current":-6.338382,"percent":0.160929,"low":-19.288261,"twenty":-5.230083,"median":-3.839524,"eighty":-3.035234,"high":-1.157457,"avg":-4.926379,"sd":3.447844,"marketCap":970666128},"quantilePoints":[{"date":"2021-04-01","current":-17.625236,"twenty":-21.149559,"median":-9.55135,"eighty":-5.814845,"marketCap":667502924},{"date":"2021-04-09","current":-16.78441,"twenty":-20.99371,"median":-9.556921,"eighty":-5.818293,"marketCap":635659194},{"date":"2021-04-16","current":-15.693263,"twenty":-20.976773,"median":-9.61126,"eighty":-5.832083,"marketCap":594335269},{"date":"2021-04-23","current":-15.7061,"twenty":-20.967275,"median":-9.612147,"eighty":-5.83668,"marketCap":594821433},{"date":"2021-04-30","current":-16.027026,"twenty":-20.940526,"median":-9.678093,"eighty":-5.856215,"marketCap":606975529},{"date":"2021-05-07","current":-16.187489,"twenty":-20.9218,"median":-9.704874,"eighty":-5.863141,"marketCap":613052577},{"date":"2021-05-14","current":-16.726644,"twenty":-20.857283,"median":-9.745168,"eighty":-5.877022,"marketCap":633471457},{"date":"2021-05-21","current":-16.811935,"twenty":-20.83323,"median":-9.785618,"eighty":-5.896668,"marketCap":636701587},{"date":"2021-05-28","current":-17.41167,"twenty":-20.75174,"median":-9.79099,"eighty":-5.90442,"marketCap":659414763},{"date":"2021-06-04","current":-17.04409,"twenty":-20.626124,"median":-9.799069,"eighty":-5.913345,"marketCap":645493784},{"date":"2021-06-11","current":-18.533755,"twenty":-20.586034,"median":-9.811455,"eighty":-5.918271,"marketCap":701910381},{"date":"2021-06-18","current":-18.075893,"twenty":-20.520152,"median":-9.843589,"eighty":-5.941255,"marketCap":684570215},{"date":"2021-06-25","current":-18.030752,"twenty":-20.513378,"median":-9.870785,"eighty":-5.97573,"marketCap":682860621},{"date":"2021-07-02","current":-15.115909,"twenty":-20.487751,"median":-9.886663,"eighty":-5.97573,"marketCap":572469705},{"date":"2021-07-09","current":-14.806368,"twenty":-20.470471,"median":-9.906604,"eighty":-5.980327,"marketCap":560746776},{"date":"2021-07-16","current":-11.577795,"twenty":-20.442465,"median":-9.931245,"eighty":-6.013653,"marketCap":535403539},{"date":"2021-07-23","current":-11.239603,"twenty":-20.41703,"median":-9.935195,"eighty":-6.024733,"marketCap":519764184},{"date":"2021-07-30","current":-10.642482,"twenty":-20.36895,"median":-10.02465,"eighty":-6.037857,"marketCap":492150948},{"date":"2021-08-06","current":-10.526229,"twenty":-20.35815,"median":-10.080791,"eighty":-6.080593,"marketCap":486774920},{"date":"2021-08-13","current":-10.203889,"twenty":-20.33223,"median":-10.138374,"eighty":-6.114291,"marketCap":471868660},{"date":"2021-08-20","current":-9.728714,"twenty":-20.32575,"median":-10.088058,"eighty":-6.156324,"marketCap":449894651},{"date":"2021-08-27","current":-11.134384,"twenty":-20.299987,"median":-10.138374,"eighty":-6.165345,"marketCap":514898441},{"date":"2021-09-03","current":-10.706341,"twenty":-20.267469,"median":-10.155617,"eighty":-6.18096,"marketCap":495104053},{"date":"2021-09-10","current":-9.578084,"twenty":-20.245297,"median":-10.155617,"eighty":-6.21797,"marketCap":493644893},{"date":"2021-09-17","current":-9.12763,"twenty":-20.213596,"median":-10.138374,"eighty":-6.250384,"marketCap":470428920},{"date":"2021-09-24","current":-8.795716,"twenty":-20.155294,"median":-10.088058,"eighty":-6.257279,"marketCap":453322414},{"date":"2021-10-01","current":-8.217238,"twenty":-20.10972,"median":-10.041851,"eighty":-6.264174,"marketCap":423508217},{"date":"2021-10-08","current":-8.250429,"twenty":-20.053588,"median":-10.013512,"eighty":-6.268771,"marketCap":425218868},{"date":"2021-10-15","current":-8.160338,"twenty":-20.004942,"median":-9.935195,"eighty":-6.268771,"marketCap":420575673},{"date":"2021-10-22","current":-7.965932,"twenty":-19.978678,"median":-9.928498,"eighty":-6.275666,"marketCap":410556148},{"date":"2021-10-29","current":-8.525443,"twenty":-19.922322,"median":-9.903412,"eighty":-6.280263,"marketCap":439392830},{"date":"2021-11-05","current":-8.610793,"twenty":-19.879677,"median":-9.877142,"eighty":-6.281869,"marketCap":443791646},{"date":"2021-11-12","current":-8.378453,"twenty":-19.831313,"median":-9.856541,"eighty":-6.336494,"marketCap":431817092},{"date":"2021-11-19","current":-7.875841,"twenty":-19.770206,"median":-9.839276,"eighty":-6.372197,"marketCap":405912954},{"date":"2021-11-26","current":-7.150372,"twenty":-19.735066,"median":-9.812511,"eighty":-6.376794,"marketCap":368523019},{"date":"2021-12-03","current":-5.86065,"twenty":-19.683562,"median":-9.803588,"eighty":-6.374313,"marketCap":302052023},{"date":"2021-12-10","current":-5.440776,"twenty":-19.629284,"median":-9.79099,"eighty":-6.281333,"marketCap":330587011},{"date":"2021-12-17","current":-5.315932,"twenty":-19.592093,"median":-9.785618,"eighty":-6.268771,"marketCap":323001373},{"date":"2021-12-23","current":-5.815308,"twenty":-19.526544,"median":-9.758677,"eighty":-6.25482,"marketCap":353343926},{"date":"2021-12-31","current":-5.328014,"twenty":-19.427593,"median":-9.73108,"eighty":-6.165345,"marketCap":323735467},{"date":"2022-01-07","current":-5.231361,"twenty":-19.359562,"median":-9.678449,"eighty":-6.028583,"marketCap":317862714},{"date":"2022-01-14","current":-5.050136,"twenty":-19.275966,"median":-9.669428,"eighty":-5.97573,"marketCap":306851304},{"date":"2022-01-21","current":-4.675604,"twenty":-19.226786,"median":-9.61126,"eighty":-5.917549,"marketCap":284094389},{"date":"2022-01-28","current":-4.719904,"twenty":-19.038973,"median":-9.602702,"eighty":-5.872455,"marketCap":286786067},{"date":"2022-02-04","current":-5.311905,"twenty":-18.920681,"median":-9.559118,"eighty":-5.832083,"marketCap":322756675},{"date":"2022-02-11","current":-6.064996,"twenty":-18.894886,"median":-9.554037,"eighty":-5.832083,"marketCap":368515203},{"date":"2022-02-18","current":-6.26233,"twenty":-18.813739,"median":-9.549042,"eighty":-5.832083,"marketCap":380505405},{"date":"2022-02-25","current":-6.471745,"twenty":-18.753258,"median":-9.540006,"eighty":-5.850469,"marketCap":393229702},{"date":"2022-03-04","current":-6.330792,"twenty":-18.736138,"median":-9.503773,"eighty":-5.859533,"marketCap":384665271},{"date":"2022-03-11","current":-5.161388,"twenty":-18.734061,"median":-9.482882,"eighty":-5.850469,"marketCap":377720709},{"date":"2022-03-18","current":-5.245231,"twenty":-18.656282,"median":-9.460337,"eighty":-5.814845,"marketCap":383856523},{"date":"2022-03-25","current":-5.372673,"twenty":-18.605577,"median":-9.448647,"eighty":-5.750642,"marketCap":393182961},{"date":"2022-04-01","current":-5.030593,"twenty":-18.569418,"median":-9.418556,"eighty":-5.678382,"marketCap":368148840},{"date":"2022-04-08","current":-4.758941,"twenty":-18.547457,"median":-9.395816,"eighty":-5.640723,"marketCap":348268802},{"date":"2022-04-14","current":-4.815954,"twenty":-18.537748,"median":-9.373611,"eighty":-5.601865,"marketCap":352441156},{"date":"2022-04-22","current":-4.564425,"twenty":-18.461984,"median":-9.338328,"eighty":-5.560538,"marketCap":334033714},{"date":"2022-04-29","current":-4.269296,"twenty":-18.405112,"median":-9.313117,"eighty":-5.535966,"marketCap":312435648},{"date":"2022-05-06","current":-3.809836,"twenty":-18.394768,"median":-9.281755,"eighty":-5.492046,"marketCap":278811388},{"date":"2022-05-13","current":-3.25647,"twenty":-18.327474,"median":-9.263667,"eighty":-5.467356,"marketCap":238315015},{"date":"2022-05-20","current":-3.025063,"twenty":-18.279297,"median":-9.242266,"eighty":-5.434907,"marketCap":221380169},{"date":"2022-05-27","current":-3.011648,"twenty":-18.229202,"median":-9.214148,"eighty":-5.406406,"marketCap":220398438},{"date":"2022-06-03","current":-3.018356,"twenty":-18.162264,"median":-9.191891,"eighty":-5.383999,"marketCap":220889304},{"date":"2022-06-10","current":-2.800363,"twenty":-18.10833,"median":-9.167406,"eighty":-5.36913,"marketCap":204936187},{"date":"2022-06-17","current":-3.0586,"twenty":-18.095239,"median":-9.157656,"eighty":-5.356176,"marketCap":223834494},{"date":"2022-06-24","current":-3.464402,"twenty":-18.072024,"median":-9.140421,"eighty":-5.344467,"marketCap":253531834},{"date":"2022-07-01","current":-3.320191,"twenty":-18.052442,"median":-9.131967,"eighty":-5.332091,"marketCap":242978234},{"date":"2022-07-08","current":-3.303411,"twenty":-18.03602,"median":-9.129602,"eighty":-5.315932,"marketCap":271999553},{"date":"2022-07-15","current":-3.679409,"twenty":-18.030752,"median":-9.12698,"eighty":-5.299824,"marketCap":302958851},{"date":"2022-07-22","current":-4.013629,"twenty":-17.971835,"median":-9.097738,"eighty":-5.27566,"marketCap":330478228},{"date":"2022-07-29","current":-3.685377,"twenty":-17.837971,"median":-9.072071,"eighty":-5.232449,"marketCap":303450269},{"date":"2022-08-05","current":-4.106137,"twenty":-17.837971,"median":-9.006003,"eighty":-5.206415,"marketCap":338095198},{"date":"2022-08-12","current":-4.422453,"twenty":-17.837971,"median":-8.885027,"eighty":-5.187177,"marketCap":364140323},{"date":"2022-08-19","current":-4.479151,"twenty":-17.837971,"median":-8.802132,"eighty":-5.165186,"marketCap":368808788},{"date":"2022-08-26","current":-4.855149,"twenty":-17.837971,"median":-8.802132,"eighty":-5.148547,"marketCap":399768087},{"date":"2022-09-02","current":-4.816355,"twenty":-17.837971,"median":-8.754215,"eighty":-5.136538,"marketCap":396573874},{"date":"2022-09-09","current":-4.373534,"twenty":-17.837971,"median":-8.667692,"eighty":-5.127353,"marketCap":390434105},{"date":"2022-09-16","current":-4.131019,"twenty":-17.837971,"median":-8.653467,"eighty":-5.107209,"marketCap":368784324},{"date":"2022-09-23","current":-3.654257,"twenty":-17.837971,"median":-8.653467,"eighty":-5.104328,"marketCap":326222824},{"date":"2022-09-30","current":-3.998738,"twenty":-17.837971,"median":-8.653467,"eighty":-5.102379,"marketCap":356975353},{"date":"2022-10-07","current":-1.364146,"twenty":-17.837971,"median":-8.653467,"eighty":-5.092671,"marketCap":121780013},{"date":"2022-10-14","current":-1.256668,"twenty":-17.837971,"median":-8.653467,"eighty":-5.077139,"marketCap":112185224},{"date":"2022-10-21","current":-1.207062,"twenty":-17.837971,"median":-8.639242,"eighty":-5.053179,"marketCap":107756860},{"date":"2022-10-28","current":-1.408239,"twenty":-17.837971,"median":-8.551485,"eighty":-5.032505,"marketCap":125716337},{"date":"2022-11-04","current":-1.438554,"twenty":-17.837971,"median":-8.509961,"eighty":-5.025059,"marketCap":128422560},{"date":"2022-11-11","current":-1.515717,"twenty":-17.837971,"median":-8.469306,"eighty":-5.015017,"marketCap":135311126},{"date":"2022-11-18","current":-1.402728,"twenty":-17.837971,"median":-8.406531,"eighty":-4.990348,"marketCap":125224297},{"date":"2022-11-25","current":-1.430286,"twenty":-17.837971,"median":-8.383195,"eighty":-4.979261,"marketCap":127684499},{"date":"2022-12-02","current":-1.482647,"twenty":-17.837971,"median":-8.383195,"eighty":-4.97089,"marketCap":132358883},{"date":"2022-12-09","current":-1.532606,"twenty":-17.837971,"median":-8.383195,"eighty":-4.958632,"marketCap":140815818},{"date":"2022-12-16","current":-1.508491,"twenty":-17.837971,"median":-8.383195,"eighty":-4.945952,"marketCap":138600184},{"date":"2022-12-23","current":-1.369164,"twenty":-17.837971,"median":-8.383195,"eighty":-4.937657,"marketCap":125798746},{"date":"2022-12-30","current":-2.509054,"twenty":-17.837971,"median":-8.383195,"eighty":-4.919678,"marketCap":230531865},{"date":"2023-01-06","current":-2.471938,"twenty":-17.837971,"median":-8.383195,"eighty":-4.911339,"marketCap":227121631},{"date":"2023-01-13","current":-2.635249,"twenty":-17.837971,"median":-8.383195,"eighty":-4.865413,"marketCap":242126663},{"date":"2023-01-20","current":-2.761444,"twenty":-17.837971,"median":-8.383195,"eighty":-4.846147,"marketCap":253721461},{"date":"2023-01-27","current":-3.017546,"twenty":-17.837971,"median":-8.383195,"eighty":-4.818838,"marketCap":277252081},{"date":"2023-02-03","current":-2.921043,"twenty":-17.837971,"median":-8.383195,"eighty":-4.787017,"marketCap":268385470},{"date":"2023-02-10","current":-2.954448,"twenty":-17.837971,"median":-8.383195,"eighty":-4.759049,"marketCap":271454682},{"date":"2023-02-17","current":-3.013834,"twenty":-17.837971,"median":-8.383195,"eighty":-4.738746,"marketCap":276911057},{"date":"2023-02-24","current":-2.783714,"twenty":-17.837971,"median":-8.383195,"eighty":-4.719904,"marketCap":255767602},{"date":"2023-03-03","current":-3.032392,"twenty":-17.837971,"median":-8.383195,"eighty":-4.706024,"marketCap":278616174},{"date":"2023-03-10","current":-2.621609,"twenty":-17.837971,"median":-8.383195,"eighty":-4.665707,"marketCap":237819288},{"date":"2023-03-17","current":-2.783577,"twenty":-17.837971,"median":-8.383195,"eighty":-4.630686,"marketCap":252512146},{"date":"2023-03-24","current":-2.452109,"twenty":-17.837971,"median":-8.383195,"eighty":-4.578352,"marketCap":222443041},{"date":"2023-03-31","current":-2.960611,"twenty":-17.79335,"median":-8.380824,"eighty":-4.538256,"marketCap":268571782},{"date":"2023-04-06","current":-2.911644,"twenty":-17.79335,"median":-8.380824,"eighty":-4.528094,"marketCap":264129755},{"date":"2023-04-14","current":-3.066078,"twenty":-17.837971,"median":-8.383195,"eighty":-4.486449,"marketCap":278139225},{"date":"2023-04-21","current":-3.073611,"twenty":-17.837971,"median":-8.383195,"eighty":-4.430028,"marketCap":278822614},{"date":"2023-04-28","current":-3.148945,"twenty":-17.837971,"median":-8.383195,"eighty":-4.400655,"marketCap":285656501},{"date":"2023-05-05","current":-3.518079,"twenty":-17.837971,"median":-8.383195,"eighty":-4.363613,"marketCap":319142550},{"date":"2023-05-12","current":-3.66498,"twenty":-17.837971,"median":-8.383195,"eighty":-4.321917,"marketCap":332468631},{"date":"2023-05-19","current":-3.917347,"twenty":-17.837971,"median":-8.383195,"eighty":-4.262531,"marketCap":355362155},{"date":"2023-05-26","current":-3.67628,"twenty":-17.837971,"median":-8.383195,"eighty":-4.171033,"marketCap":333493714},{"date":"2023-06-02","current":-3.796813,"twenty":-17.837971,"median":-8.383195,"eighty":-4.121066,"marketCap":344427935},{"date":"2023-06-09","current":-3.762913,"twenty":-17.837971,"median":-8.383195,"eighty":-4.074132,"marketCap":341352685},{"date":"2023-06-16","current":-3.627313,"twenty":-17.837971,"median":-8.383195,"eighty":-4.015419,"marketCap":329051687},{"date":"2023-06-23","current":-3.74408,"twenty":-17.882593,"median":-8.385161,"eighty":-3.981381,"marketCap":339644213},{"date":"2023-06-30","current":-3.390012,"twenty":-17.927214,"median":-8.387126,"eighty":-3.936556,"marketCap":307524942},{"date":"2023-07-07","current":-3.371179,"twenty":-17.927214,"median":-8.387126,"eighty":-3.918102,"marketCap":305816470},{"date":"2023-07-14","current":-3.596288,"twenty":-17.927214,"median":-8.387126,"eighty":-3.881733,"marketCap":334120355},{"date":"2023-07-21","current":-3.555756,"twenty":-17.927214,"median":-8.387126,"eighty":-3.85357,"marketCap":330354654},{"date":"2023-07-28","current":-3.518909,"twenty":-17.927214,"median":-8.387126,"eighty":-3.806286,"marketCap":326931290},{"date":"2023-08-04","current":-4.078987,"twenty":-17.927214,"median":-8.383195,"eighty":-3.787773,"marketCap":378966428},{"date":"2023-08-11","current":-3.998083,"twenty":-17.927214,"median":-8.359487,"eighty":-3.787773,"marketCap":371449889},{"date":"2023-08-18","current":-4.031277,"twenty":-17.927214,"median":-8.304947,"eighty":-3.787773,"marketCap":374533883},{"date":"2023-08-25","current":-3.911409,"twenty":-17.927214,"median":-8.276306,"eighty":-3.787773,"marketCap":363397239},{"date":"2023-09-01","current":-4.001771,"twenty":-17.927214,"median":-8.250429,"eighty":-3.787773,"marketCap":371792555},{"date":"2023-09-08","current":-3.918109,"twenty":-17.612375,"median":-8.208265,"eighty":-3.787773,"marketCap":372933484},{"date":"2023-09-15","current":-3.603649,"twenty":-17.509147,"median":-8.131888,"eighty":-3.767896,"marketCap":343002476},{"date":"2023-09-22","current":-3.455454,"twenty":-17.302041,"median":-8.043907,"eighty":-3.739154,"marketCap":328897058},{"date":"2023-09-29","current":-3.491599,"twenty":-17.040221,"median":-8.003865,"eighty":-3.711696,"marketCap":332337404},{"date":"2023-10-06","current":-3.545817,"twenty":-16.78441,"median":-7.931827,"eighty":-3.68029,"marketCap":337497922},{"date":"2023-10-13","current":-3.318104,"twenty":-16.726644,"median":-7.865046,"eighty":-3.665109,"marketCap":315823744},{"date":"2023-10-20","current":-3.198825,"twenty":-16.484024,"median":-7.827443,"eighty":-3.643446,"marketCap":304470603},{"date":"2023-10-27","current":-2.909666,"twenty":-16.240274,"median":-7.800236,"eighty":-3.634846,"marketCap":276947836},{"date":"2023-11-03","current":-3.131957,"twenty":-16.139992,"median":-7.76349,"eighty":-3.619654,"marketCap":298105963},{"date":"2023-11-10","current":-2.833762,"twenty":-16.012905,"median":-7.693722,"eighty":-3.600705,"marketCap":269723110},{"date":"2023-11-17","current":-2.750628,"twenty":-15.893521,"median":-7.611776,"eighty":-3.579671,"marketCap":261810315},{"date":"2023-11-24","current":-2.945811,"twenty":-15.740872,"median":-7.585145,"eighty":-3.551016,"marketCap":280388182},{"date":"2023-12-01","current":-3.050631,"twenty":-15.367493,"median":-7.560499,"eighty":-3.53878,"marketCap":290365185},{"date":"2023-12-08","current":-3.082194,"twenty":-14.897334,"median":-7.527267,"eighty":-3.509271,"marketCap":309991619},{"date":"2023-12-15","current":-3.607919,"twenty":-14.808948,"median":-7.401044,"eighty":-3.490153,"marketCap":362866444},{"date":"2023-12-22","current":-3.8725,"twenty":-14.50411,"median":-7.357088,"eighty":-3.490153,"marketCap":389476650},{"date":"2023-12-29","current":-4.150825,"twenty":-14.108779,"median":-7.326046,"eighty":-3.488707,"marketCap":417469204},{"date":"2024-01-05","current":-4.030561,"twenty":-13.968443,"median":-7.294625,"eighty":-3.487262,"marketCap":405373656},{"date":"2024-01-12","current":-4.508181,"twenty":-13.685978,"median":-7.184004,"eighty":-3.487262,"marketCap":453410262},{"date":"2024-01-19","current":-4.281397,"twenty":-13.439469,"median":-7.118384,"eighty":-3.485816,"marketCap":430601514},{"date":"2024-01-26","current":-4.415406,"twenty":-13.314139,"median":-7.07687,"eighty":-3.487262,"marketCap":444079410},{"date":"2024-02-02","current":-5.408442,"twenty":-13.179889,"median":-7.005442,"eighty":-3.487262,"marketCap":543954079},{"date":"2024-02-09","current":-5.119809,"twenty":-12.983332,"median":-6.875358,"eighty":-3.487262,"marketCap":514924764},{"date":"2024-02-16","current":-5.071703,"twenty":-12.906354,"median":-6.785901,"eighty":-3.487262,"marketCap":510086544},{"date":"2024-02-23","current":-5.200236,"twenty":-12.550065,"median":-6.722697,"eighty":-3.487262,"marketCap":523013764},{"date":"2024-03-01","current":-5.642546,"twenty":-12.446128,"median":-6.628065,"eighty":-3.488707,"marketCap":567499036},{"date":"2024-03-08","current":-5.789293,"twenty":-12.214813,"median":-6.524463,"eighty":-3.488707,"marketCap":582258169},{"date":"2024-03-15","current":-4.84211,"twenty":-11.98198,"median":-6.473684,"eighty":-3.488707,"marketCap":524400519},{"date":"2024-03-22","current":-4.733036,"twenty":-11.754396,"median":-6.452984,"eighty":-3.488707,"marketCap":512587796},{"date":"2024-03-28","current":-4.312322,"twenty":-11.689964,"median":-6.424518,"eighty":-3.488707,"marketCap":467024436},{"date":"2024-04-05","current":-4.366859,"twenty":-11.578128,"median":-6.377487,"eighty":-3.487262,"marketCap":472930798},{"date":"2024-04-12","current":-4.713558,"twenty":-11.456327,"median":-6.282939,"eighty":-3.487262,"marketCap":510478381},{"date":"2024-04-19","current":-4.479828,"twenty":-11.332917,"median":-6.268771,"eighty":-3.487262,"marketCap":485165404},{"date":"2024-04-26","current":-4.086383,"twenty":-11.226921,"median":-6.257279,"eighty":-3.488707,"marketCap":442555225},{"date":"2024-05-03","current":-4.740827,"twenty":-11.166695,"median":-6.165345,"eighty":-3.488707,"marketCap":513431562},{"date":"2024-05-10","current":-4.709663,"twenty":-11.03278,"median":-6.075064,"eighty":-3.488707,"marketCap":510056498},{"date":"2024-05-17","current":-4.701872,"twenty":-10.939114,"median":-5.978603,"eighty":-3.488707,"marketCap":509212732},{"date":"2024-05-24","current":-4.398023,"twenty":-10.832897,"median":-5.927156,"eighty":-3.488707,"marketCap":476305861},{"date":"2024-05-31","current":-4.546052,"twenty":-10.777169,"median":-5.860731,"eighty":-3.488707,"marketCap":492337414},{"date":"2024-06-07","current":-4.549947,"twenty":-10.70117,"median":-5.823695,"eighty":-3.488707,"marketCap":492759297},{"date":"2024-06-14","current":-4.701872,"twenty":-10.638259,"median":-5.787705,"eighty":-3.488707,"marketCap":509212732},{"date":"2024-06-21","current":-4.57332,"twenty":-10.590761,"median":-5.734403,"eighty":-3.487262,"marketCap":495290595},{"date":"2024-06-28","current":-4.588902,"twenty":-10.545998,"median":-5.659081,"eighty":-3.487262,"marketCap":496978126},{"date":"2024-07-05","current":-4.592798,"twenty":-10.487182,"median":-5.601865,"eighty":-3.487262,"marketCap":497400009},{"date":"2024-07-12","current":-4.40031,"twenty":-10.410809,"median":-5.535069,"eighty":-3.487262,"marketCap":557272836},{"date":"2024-07-19","current":-4.909855,"twenty":-10.348643,"median":-5.493407,"eighty":-3.487262,"marketCap":621803663},{"date":"2024-07-26","current":-4.990842,"twenty":-10.271352,"median":-5.464346,"eighty":-3.487262,"marketCap":632060219},{"date":"2024-08-02","current":-4.444178,"twenty":-10.223016,"median":-5.409564,"eighty":-3.487262,"marketCap":562828470},{"date":"2024-08-09","current":-4.353067,"twenty":-10.163072,"median":-5.345843,"eighty":-3.487262,"marketCap":551289846},{"date":"2024-08-16","current":-4.049365,"twenty":-10.085151,"median":-5.315932,"eighty":-3.487262,"marketCap":512827764},{"date":"2024-08-23","current":-4.29649,"twenty":-10.011936,"median":-5.245231,"eighty":-3.487262,"marketCap":544124674},{"date":"2024-08-30","current":-4.555028,"twenty":-9.928269,"median":-5.200236,"eighty":-3.487262,"marketCap":576866935},{"date":"2024-09-06","current":-3.761578,"twenty":-9.858836,"median":-5.147973,"eighty":-3.487262,"marketCap":533278924},{"date":"2024-09-13","current":-3.395784,"twenty":-9.80126,"median":-5.103109,"eighty":-3.468426,"marketCap":481420358},{"date":"2024-09-20","current":-3.197646,"twenty":-9.730134,"median":-5.088884,"eighty":-3.451786,"marketCap":453330301},{"date":"2024-09-27","current":-3.761578,"twenty":-9.604413,"median":-5.050715,"eighty":-3.433767,"marketCap":533278924},{"date":"2024-10-04","current":-3.462847,"twenty":-9.550427,"median":-5.027239,"eighty":-3.433767,"marketCap":490927761},{"date":"2024-10-11","current":-3.54515,"twenty":-9.550427,"median":-4.981673,"eighty":-3.417997,"marketCap":502595939},{"date":"2024-10-18","current":-3.810351,"twenty":-9.545428,"median":-4.947656,"eighty":-3.417997,"marketCap":540193400},{"date":"2024-10-25","current":-3.560392,"twenty":-9.489729,"median":-4.917815,"eighty":-3.417997,"marketCap":504756712},{"date":"2024-11-01","current":-3.234226,"twenty":-9.457913,"median":-4.90648,"eighty":-3.408677,"marketCap":458516157},{"date":"2024-11-08","current":-3.960983,"twenty":-9.372815,"median":-4.865483,"eighty":-3.408677,"marketCap":561548535},{"date":"2024-11-15","current":-3.294455,"twenty":-9.298489,"median":-4.855149,"eighty":-3.403274,"marketCap":467054829},{"date":"2024-11-22","current":-3.523574,"twenty":-9.214148,"median":-4.816355,"eighty":-3.394581,"marketCap":499537040},{"date":"2024-11-29","current":-3.49233,"twenty":-9.137375,"median":-4.791748,"eighty":-3.394581,"marketCap":495107648},{"date":"2024-12-06","current":-3.099941,"twenty":-9.08314,"median":-4.7642,"eighty":-3.372248,"marketCap":484790442},{"date":"2024-12-13","current":-2.746023,"twenty":-8.871686,"median":-4.744722,"eighty":-3.350974,"marketCap":429442298},{"date":"2024-12-20","current":-2.641744,"twenty":-8.745815,"median":-4.72914,"eighty":-3.318939,"marketCap":413134362},{"date":"2024-12-27","current":-2.695463,"twenty":-8.664771,"median":-4.718696,"eighty":-3.301406,"marketCap":421535420},{"date":"2025-01-03","current":-2.853462,"twenty":-8.597516,"median":-4.709663,"eighty":-3.283415,"marketCap":446244413},{"date":"2025-01-10","current":-2.480585,"twenty":-8.54441,"median":-4.701872,"eighty":-3.267552,"marketCap":387931190},{"date":"2025-01-17","current":-2.622784,"twenty":-8.503884,"median":-4.677052,"eighty":-3.245933,"marketCap":410169283},{"date":"2025-01-24","current":-2.720743,"twenty":-8.466641,"median":-4.669262,"eighty":-3.229642,"marketCap":425488859},{"date":"2025-01-31","current":-2.815543,"twenty":-8.406517,"median":-4.647335,"eighty":-3.215033,"marketCap":440314255},{"date":"2025-02-07","current":-2.907182,"twenty":-8.377475,"median":-4.631753,"eighty":-3.191832,"marketCap":454645471},{"date":"2025-02-14","current":-3.084141,"twenty":-8.350549,"median":-4.619735,"eighty":-3.173524,"marketCap":482319543},{"date":"2025-02-21","current":-3.16946,"twenty":-8.304475,"median":-4.608379,"eighty":-3.162031,"marketCap":495662399},{"date":"2025-02-28","current":-3.600798,"twenty":-8.275872,"median":-4.589232,"eighty":-3.162031,"marketCap":563117950},{"date":"2025-03-07","current":-3.766697,"twenty":-8.245688,"median":-4.564425,"eighty":-3.160174,"marketCap":589062393},{"date":"2025-03-14","current":-3.561879,"twenty":-8.217238,"median":-4.553843,"eighty":-3.160174,"marketCap":626417013},{"date":"2025-03-21","current":-3.36117,"twenty":-8.217238,"median":-4.553843,"eighty":-3.160174,"marketCap":591118912},{"date":"2025-03-28","current":-3.372478,"twenty":-8.217238,"median":-4.553843,"eighty":-3.160174,"marketCap":593107537},{"date":"2025-04-04","current":-3.027597,"twenty":-8.217238,"median":-4.553843,"eighty":-3.141709,"marketCap":532454461},{"date":"2025-04-11","current":-3.248095,"twenty":-8.216635,"median":-4.542442,"eighty":-3.132319,"marketCap":571232657},{"date":"2025-04-17","current":-3.392266,"twenty":-8.216635,"median":-4.518399,"eighty":-3.132319,"marketCap":596587632},{"date":"2025-04-25","current":-3.672128,"twenty":-8.217238,"median":-4.483724,"eighty":-3.131957,"marketCap":645806111},{"date":"2025-05-02","current":-3.830434,"twenty":-8.217238,"median":-4.463511,"eighty":-3.131957,"marketCap":673646867},{"date":"2025-05-09","current":-3.363997,"twenty":-8.217238,"median":-4.440873,"eighty":-3.131957,"marketCap":591616068},{"date":"2025-05-16","current":-3.372478,"twenty":-8.217238,"median":-4.415406,"eighty":-3.131957,"marketCap":593107537},{"date":"2025-05-23","current":-3.228306,"twenty":-8.217238,"median":-4.40031,"eighty":-3.131957,"marketCap":567752563},{"date":"2025-05-30","current":-3.36117,"twenty":-8.217238,"median":-4.386336,"eighty":-3.131957,"marketCap":591118912},{"date":"2025-06-06","current":-3.901106,"twenty":-8.217238,"median":-4.373534,"eighty":-3.131957,"marketCap":686075776},{"date":"2025-06-13","current":-3.700397,"twenty":-8.217238,"median":-4.366859,"eighty":-3.131957,"marketCap":650777675},{"date":"2025-06-20","current":-3.479899,"twenty":-8.222928,"median":-4.3318,"eighty":-3.131682,"marketCap":611999479},{"date":"2025-06-27","current":-3.250922,"twenty":-8.222928,"median":-4.314723,"eighty":-3.131682,"marketCap":571729814},{"date":"2025-07-03","current":-3.386612,"twenty":-8.222928,"median":-4.300635,"eighty":-3.131682,"marketCap":595593319},{"date":"2025-07-11","current":-4.20733,"twenty":-8.222928,"median":-4.287148,"eighty":-3.131682,"marketCap":771809364},{"date":"2025-07-18","current":-4.342962,"twenty":-8.222928,"median":-4.27265,"eighty":-3.131682,"marketCap":796690388},{"date":"2025-07-25","current":-4.231743,"twenty":-8.222928,"median":-4.248806,"eighty":-3.131682,"marketCap":776287948},{"date":"2025-08-01","current":-3.69735,"twenty":-8.222928,"median":-4.224101,"eighty":-3.131682,"marketCap":678256714},{"date":"2025-08-08","current":-3.434223,"twenty":-8.222928,"median":-4.216401,"eighty":-3.131682,"marketCap":629987527},{"date":"2025-08-15","current":-3.51289,"twenty":-8.222928,"median":-4.192768,"eighty":-3.131682,"marketCap":644418521},{"date":"2025-08-22","current":-3.529145,"twenty":-8.204398,"median":-4.170246,"eighty":-3.131682,"marketCap":647400457},{"date":"2025-08-29","current":-3.707349,"twenty":-8.168957,"median":-4.130686,"eighty":-3.131682,"marketCap":680091008},{"date":"2025-09-05","current":-4.171111,"twenty":-8.177575,"median":-4.106137,"eighty":-3.131408,"marketCap":765165309},{"date":"2025-09-12","current":-3.684199,"twenty":-8.116715,"median":-4.106137,"eighty":-3.131682,"marketCap":748249687},{"date":"2025-09-19","current":-3.452848,"twenty":-8.116715,"median":-4.078822,"eighty":-3.131682,"marketCap":701263043},{"date":"2025-09-26","current":-3.008804,"twenty":-8.116715,"median":-4.061095,"eighty":-3.130143,"marketCap":611078999},{"date":"2025-10-03","current":-2.92298,"twenty":-8.116715,"median":-4.047697,"eighty":-3.102006,"marketCap":593648469},{"date":"2025-10-10","current":-2.937906,"twenty":-8.116715,"median":-4.030919,"eighty":-3.090104,"marketCap":596679865},{"date":"2025-10-17","current":-2.746357,"twenty":-8.047278,"median":-4.012645,"eighty":-3.08457,"marketCap":557776944},{"date":"2025-10-24","current":-2.736407,"twenty":-7.935623,"median":-3.99841,"eighty":-3.073352,"marketCap":555756014},{"date":"2025-10-31","current":-2.728944,"twenty":-7.853444,"median":-3.981381,"eighty":-3.058674,"marketCap":554240315},{"date":"2025-11-07","current":-2.709043,"twenty":-7.725057,"median":-3.970212,"eighty":-3.042702,"marketCap":550198453},{"date":"2025-11-14","current":-3.257808,"twenty":-7.558621,"median":-3.949337,"eighty":-3.035234,"marketCap":661650975},{"date":"2025-11-21","current":-3.240386,"twenty":-7.343932,"median":-3.927885,"eighty":-3.035234,"marketCap":658112734},{"date":"2025-11-28","current":-3.601259,"twenty":-7.111083,"median":-3.922265,"eighty":-3.035234,"marketCap":731404859},{"date":"2025-12-05","current":-4.081593,"twenty":-6.578869,"median":-3.9153,"eighty":-3.035234,"marketCap":828959205},{"date":"2025-12-12","current":-4.206031,"twenty":-6.450633,"median":-3.9153,"eighty":-3.035234,"marketCap":854232351},{"date":"2025-12-19","current":-3.733164,"twenty":-6.385563,"median":-3.910611,"eighty":-3.035234,"marketCap":758194395},{"date":"2025-12-26","current":-3.929777,"twenty":-6.292131,"median":-3.909499,"eighty":-3.035234,"marketCap":798125966},{"date":"2026-01-02","current":-4.019373,"twenty":-6.170495,"median":-3.90582,"eighty":-3.035234,"marketCap":816322631},{"date":"2026-01-09","current":-3.937244,"twenty":-6.047814,"median":-3.902294,"eighty":-3.035234,"marketCap":799642355},{"date":"2026-01-16","current":-3.723209,"twenty":-5.848209,"median":-3.896085,"eighty":-3.035234,"marketCap":756172543},{"date":"2026-01-23","current":-4.116435,"twenty":-5.781026,"median":-3.889172,"eighty":-3.035234,"marketCap":836035686},{"date":"2026-01-30","current":-3.894934,"twenty":-5.662941,"median":-3.874645,"eighty":-3.035234,"marketCap":791049485},{"date":"2026-02-06","current":-3.583837,"twenty":-5.563204,"median":-3.865345,"eighty":-3.035234,"marketCap":727866619},{"date":"2026-02-13","current":-3.763029,"twenty":-5.513485,"median":-3.848771,"eighty":-3.035234,"marketCap":764259950},{"date":"2026-02-20","current":-3.954665,"twenty":-5.480203,"median":-3.839524,"eighty":-3.035234,"marketCap":803180595},{"date":"2026-02-27","current":-3.922311,"twenty":-5.441241,"median":-3.839524,"eighty":-3.035234,"marketCap":796609577},{"date":"2026-03-06","current":-4.034306,"twenty":-5.385594,"median":-3.839524,"eighty":-3.035234,"marketCap":819355409},{"date":"2026-03-13","current":-4.325493,"twenty":-5.328819,"median":-3.839524,"eighty":-3.035234,"marketCap":878494572},{"date":"2026-03-20","current":-4.089059,"twenty":-5.279687,"median":-3.839524,"eighty":-3.035234,"marketCap":830475593},{"date":"2026-03-27","current":-5.908392,"twenty":-5.230083,"median":-3.839524,"eighty":-3.035234,"marketCap":970666128}],"updateTime":1774747134551},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KALV\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618948537","title":"U.S. Earnings Preview: Before Market Open March 11","url":"https://stock-news.laohu8.com/highlight/detail?id=2618948537","media":"Dow Jones","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618948537?lang=en_us&edition=fundamental","pubTime":"2026-03-11 17:31","pubTimestamp":1773221460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.The following companies are among those expected to report their latest financial results before the market opens.Campbell's Co.'s second-quarter EPS is forecast at 55 cents, compared with 58 cents in the prior-year period. Adjusted EPS is forecast at 57 cents.Sprinklr Inc.'s fourth-quarter EPS is forecast at a loss of 14 cents. Adjusted EPS is forecast at 10 cents.Taysha Gene Therapies Inc.'s fourth-quarter EPS is forecast at a loss of 10 cents, compared with a loss of 7 cents in the prior-year period. Adjusted EPS is forecast at a loss of 9 cents.KalVista Pharmaceuticals Inc.'s fourth-quarter EPS is forecast at a loss of $1.00, compared with a loss of 92 cents in the prior-year period. Adjusted EPS is forecast at a loss of 67 cents.Sonida Senior Living Corp.'s fourth-quarter EPS is forecast at a loss of $1.24, compared with a loss of 49 cents in the prior-year period.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4166","BK4023","BK4185","BK4585","BK4588","CPB","OPFI","BK4212","BK4123","KALV","ACTG","CXM","TSHA","BK4139","BK4539","SNDA","BK4164"],"gpt_icon":0},{"id":"2616532731","title":"KalVista Pharmaceuticals Grants 6,750 Inducement Stock Options to New Hire","url":"https://stock-news.laohu8.com/highlight/detail?id=2616532731","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616532731?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:00","pubTimestamp":1772625630,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals said its board compensation committee granted a newly hired employee stock options to buy 6,750 shares on March 1, 2026, with an exercise price set at the first reported closing price after the grant date. One-quarter of the options vest after one year, with the remainder vesting monthly over the following three years, subject to continued service. The options have a 10-year term and are issued under KalVista’s Inducement Equity Incentive Plan and related option agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on March 04, 2026, and is solely responsible for the information contained therein","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL4cXZ0p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2616532903","title":"Kalvista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616532903","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616532903?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:00","pubTimestamp":1772625602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nTUA6VV70T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2616303574","title":"DRI Healthcare posts Q4 adjusted EBITDA of USD 46.2 million +25.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616303574","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616303574?lang=en_us&edition=fundamental","pubTime":"2026-03-04 08:08","pubTimestamp":1772582904,"startTime":"0","endTime":"0","summary":"DRI Healthcare posts Q4 adjusted EBITDA of USD 46.2 million +25.1%               DRI Healthcare reported Q4 FY2025 total income of USD 61.7 million and total cash receipts of USD 50.7 million, with ad","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDLb5zNNQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2616390873","title":"KalVista highlights new EKTERLY sebetralstat trial data showing high patient satisfaction and earlier HAE attack treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2616390873","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616390873?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:00","pubTimestamp":1772452835,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Inc. announced new data from its sebetralstat clinical trial program evaluating EKTERLY , an oral on-demand treatment for hereditary angioedema attacks. The company said the results were presented at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting and the Western Society of Allergy, Asthma & Immunology 63rd Annual Scientific Session, including findings from the KONFIDENT-S open-label study on treatment patterns and patient satisfaction and analyses of response drivers in placebo-controlled trials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on March 02, 2026, and is solely","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL30JKFT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2614089249","title":"KalVista Pharmaceuticals to Present at TD Cowen Annual Healthcare Conference and Citizens Life Sciences Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2614089249","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614089249?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:00","pubTimestamp":1772020816,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals to Present at TD Cowen Annual Healthcare Conference and Citizens Life Sciences Conference               KalVista Pharmaceuticals, Inc. will participate in a fireside chat at t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL6SQzvz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2612305443","title":"BRIEF-Kalvista Pharmaceuticals Announces Inclusion Of Ekterly® As A First-Line Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2612305443","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612305443?lang=en_us&edition=fundamental","pubTime":"2026-02-18 20:27","pubTimestamp":1771417668,"startTime":"0","endTime":"0","summary":"BRIEF-Kalvista Pharmaceuticals Announces Inclusion Of Ekterly As A First-Line Therapy Feb 18 (Reuters) - Kalvista Pharmaceuticals Inc KALV.O:KALVISTA PHARMACEUTICALS ANNOUNCES INCLUSION OF EKTERLY (SE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nTUA4HHQPK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2612485464","title":"International Pediatric HAE Guideline Recommends KalVista’s EKTERLY as First-Line Acute Therapy for Adolescents 12+","url":"https://stock-news.laohu8.com/highlight/detail?id=2612485464","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612485464?lang=en_us&edition=fundamental","pubTime":"2026-02-18 20:02","pubTimestamp":1771416126,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Inc. said a newly published International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary Angioedema recommends EKTERLY  as a first-line therapy for the acute treatment of hereditary angioedema attacks in adolescents aged 12 and older. The company noted EKTERLY launched in the U.S. and Germany months ago and received seven global regulatory approvals in 2025, and said it is approved in the U.S., EU, UK, Switzerland, Australia, Singapore and Japan for acute HAE attacks in patients 12 and older. KalVista also said it is advancing the KONFIDENT-KID trial and plans to submit a new drug application for sebetralstat in patients aged 2 to 11 in the third quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financia","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL3qyjZD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2612448569","title":"Kalvista Pharmaceuticals Inc - Advancing Konfident-Kid Trial, Plans Drug Application for Sebetralstat in Patients Aged 2 to 11 in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2612448569","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612448569?lang=en_us&edition=fundamental","pubTime":"2026-02-18 20:00","pubTimestamp":1771416001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nTUA4HHQPK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2612448372","title":"Kalvista Pharmaceuticals Announces Inclusion of Ekterly® (Sebetralstat) as a First-Line Therapy for Adolescents 12 and Older in International Pediatric Hae Guideline","url":"https://stock-news.laohu8.com/highlight/detail?id=2612448372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612448372?lang=en_us&edition=fundamental","pubTime":"2026-02-18 20:00","pubTimestamp":1771416001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nTUA4HHQPK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2610923884","title":"KalVista Pharmaceuticals Announces New Clinical Data on EKTERLY® (sebetralstat) for Hereditary Angioedema at AAAAI 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2610923884","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610923884?lang=en_us&edition=fundamental","pubTime":"2026-02-12 20:01","pubTimestamp":1770897689,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Inc. has announced the acceptance of three abstracts for presentation at the 2026 American Academy of Allergy, Asthma & Immunology  Annual Meeting, scheduled to take place in Philadelphia, Pennsylvania, from February 27 to March 2, 2026. The presentations will include data on EKTERLY , with two poster sessions scheduled for February 27 covering response drivers in sebetralstat placebo-controlled clinical trials and on-demand treatment patterns in the KONFIDENT-S study. An additional late-breaking poster on the management and burden of hereditary angioedema attacks will be presented on March 1. The results from these studies will be presented at the meeting, and links to all presentations will be made available on the KalVista website under Publications.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informatio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL5ttTFW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2608873947","title":"KalVista Pharmaceuticals Grants Stock Options to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2608873947","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608873947?lang=en_us&edition=fundamental","pubTime":"2026-02-03 20:00","pubTimestamp":1770120050,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Inc. has granted inducement stock options to six newly-hired employees, allowing them to purchase a total of 96,750 shares of KalVista common stock. The options have an exercise price equal to the closing price of KalVista shares on the first trading day after the grant date. One-fourth of the options will vest on the one-year anniversary of the vesting commencement date, with the remaining options vesting in equal monthly installments over the following three years. Each option carries a 10-year term and is governed by KalVista’s Inducement Equity Incentive Plan and a stock option agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kalvista Pharmaceuticals Inc. published the original content used to gene","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL8mTMNV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2608873864","title":"Kalvista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608873864","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608873864?lang=en_us&edition=fundamental","pubTime":"2026-02-03 20:00","pubTimestamp":1770120000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUA1SGMMZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KALV"],"gpt_icon":0},{"id":"2605404149","title":"KalVista’s Pediatric HAE Trial for Sebetralstat Reaches Completion, Setting Up a Key Catalyst for KALV","url":"https://stock-news.laohu8.com/highlight/detail?id=2605404149","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605404149?lang=en_us&edition=fundamental","pubTime":"2026-01-24 00:30","pubTimestamp":1769185848,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals, Inc. ($KALV) announced an update on their ongoing clinical study. Study Overview KalVista Pharmaceuticals is running a pe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kalvistas-pediatric-hae-trial-for-sebetralstat-reaches-completion-setting-up-a-key-catalyst-for-kalv?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kalvistas-pediatric-hae-trial-for-sebetralstat-reaches-completion-setting-up-a-key-catalyst-for-kalv?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B64QTZ34.USD","KALV","IE00B19Z6F94.USD","LU1169589451.USD","LU0205194284.USD","BK4139","LU0012050646.USD","LU0205193047.USD","LU1169590202.USD","BK4198","LU0106261612.USD","IE0034390439.USD","IE00BLDYK493.USD","HAE"],"gpt_icon":0},{"id":"2602376849","title":"Stifel Nicolaus Sticks to Their Buy Rating for KalVista Pharmaceuticals (KALV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376849","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376849?lang=en_us&edition=fundamental","pubTime":"2026-01-09 20:56","pubTimestamp":1767963397,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on KalVista Pharmaceuticals today and set a price target of $39.00. Matteis covers the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-their-buy-rating-for-kalvista-pharmaceuticals-kalv-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-their-buy-rating-for-kalvista-pharmaceuticals-kalv-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KALV","SF"],"gpt_icon":0},{"id":"2602782433","title":"Kalvista Pharmaceuticals Inc : Needham Raises Target Price to $35 From $32","url":"https://stock-news.laohu8.com/highlight/detail?id=2602782433","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602782433?lang=en_us&edition=fundamental","pubTime":"2026-01-09 20:07","pubTimestamp":1767960431,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA12S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2602327081","title":"KalVista price target raised to $37 from $27 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2602327081","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602327081?lang=en_us&edition=fundamental","pubTime":"2026-01-09 19:10","pubTimestamp":1767957040,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Andrew Fein raised the firm’s price target on KalVista (KALV) to $37 from $27 and keeps a Buy rating on the shares. The fir...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kalvista-price-target-raised-to-37-from-27-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kalvista-price-target-raised-to-37-from-27-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2602967327","title":"Greenbrier, General Motors And 3 Stocks To Watch Heading Into Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2602967327","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602967327?lang=en_us&edition=fundamental","pubTime":"2026-01-09 19:06","pubTimestamp":1767956791,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/26/01/49807470/greenbrier-general-motors-and-3-stocks-to-watch-heading-into-friday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0208291251.USD","AEHR","IE00B775SV38.USD","LU0070302665.USD","BK4516","BK4099","LU1201861249.SGD","KALV","BK4561","BK4147","IE00B3S45H60.SGD","LU0345770308.USD","BK4139","BK4588","LU0757428866.USD","BK4563","GBX","BK4574","LU0211331839.USD","BK4566","LU0162691827.USD","GM","LU0130518102.USD","LU0648001328.SGD","LU0072461881.USD","LU0130102774.USD","LU0320765489.SGD","BK4596","LU0130517989.USD","LU0345770993.USD","WDFC","BK4559","LU0648000940.SGD","LU1815336091.USD","BK4555","LU0130103400.USD","BK4149","LU1496350502.SGD","LU0477156797.USD","LU0477156953.USD","LU1201861165.SGD","BK4018","LU0980610538.SGD","LU0006061336.USD"],"gpt_icon":0},{"id":"2602319748","title":"KalVista Pharmaceuticals Gains on Strong Demand for Genetic-Disorder Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2602319748","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602319748?lang=en_us&edition=fundamental","pubTime":"2026-01-09 07:53","pubTimestamp":1767916380,"startTime":"0","endTime":"0","summary":"Shares of KalVista Pharmaceuticals climbed after the company said it saw strong demand for Ekterly, a treatment for a rare genetic disorder, in its latest quarter.The stock rose 14%, to $17.99, in after-hours trading on Thursday. Through market close, shares have surged 92% in the past 12 months.Chief Executive Ben Palleiko said the company is extremely pleased with its performance since offering Ekterly, an oral treatment for hereditary angioedema, in July.\"Fundamental demand has remained strong, with some effects from seasonal variability, and we are encouraged by the continued high level of interest in switching to Ekterly,\" Palleiko said.The Framingham, Mass., company now expects net product revenue of $35 million for the fourth quarter and $49 million for 2025. Analysts polled by FactSet had expected full-year revenue of $32.7 million.The company is also seeing strong uptake for Ekterly in Germany, Palleiko said, noting early prescribing behaviors in the country have mirrored the ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"KalVista Pharmaceuticals Gains on Strong Demand for Genetic-Disorder Treatment","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0},{"id":"2602313867","title":"Kalvista Pharmaceuticals Showcases EKTERLY as First Oral On-Demand Therapy for Hereditary Angioedema","url":"https://stock-news.laohu8.com/highlight/detail?id=2602313867","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602313867?lang=en_us&edition=fundamental","pubTime":"2026-01-09 05:30","pubTimestamp":1767907858,"startTime":"0","endTime":"0","summary":"KalVista Pharmaceuticals Inc. has released a corporate presentation highlighting its focus on rare disease therapies, with emphasis on its flagship product, EKTERLY. EKTERLY is described as the first and only oral on-demand therapy for hereditary angioedema , approved for use in adults and pediatric patients aged 12 years and older. The company reports that EKTERLY is now available in seven key global markets, including the US, EU, UK, Switzerland, Australia, Japan, and Singapore, with plans to expand its indication to younger pediatric patients in 2027. The presentation details the significant burden of HAE, a rare condition characterized by unpredictable and potentially life-threatening swelling attacks, and positions EKTERLY as a foundational treatment option for acute HAE attacks. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL63tCbH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KALV","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":73,"code":"91000000","status":"200"}]}}